Literature DB >> 11854222

A superoxide dismutase C mutant of Haemophilus ducreyi is virulent in human volunteers.

Cliffton T H Bong1, Kate R Fortney, Barry P Katz, Antoinette F Hood, Lani R San Mateo, Thomas H Kawula, Stanley M Spinola.   

Abstract

Haemophilus ducreyi produces a periplasmic copper-zinc superoxide dismutase (Cu-Zn SOD), which is thought to protect the organism from exogenous reactive oxygen species generated by neutrophils during an inflammatory response. We had previously identified the gene, sodC, responsible for the production and secretion of Cu-Zn SOD and constructed an isogenic H. ducreyi strain with a mutation in the sodC gene (35000HP-sodC-cat). Compared to the parent, the mutant does not survive in the presence of exogenous superoxide (L. R. San Mateo, M. Hobbs, and T. H. Kawula, Mol. Microbiol. 27:391-404, 1998) and is impaired in the swine model of H. ducreyi infection (L. R. San Mateo, K. L. Toffer, P. E. Orndorff, and T. H. Kawula, Infect. Immun. 67:5345-5351, 1999). To test whether Cu-Zn SOD is important for bacterial survival in vivo, six human volunteers were experimentally infected with 35000HP and 35000HP-sodC-cat and observed for papule and pustule formation. Papules developed at similar rates at sites inoculated with the mutant or parent. The pustule formation rates were 75% (95% confidence intervals [CI], 43 to 95%) at 12 parent-inoculated sites and 67% (95% CI, 41 to 88%) at 18 mutant-inoculated sites (P = 0.47). There was no significant difference in levels of H. ducreyi recovery from mutant- and parent-inoculated biopsy sites. These results suggest that expression of Cu-Zn SOD does not play a major role in the survival of this pathogen in the initial stages of experimental infection of humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11854222      PMCID: PMC127809          DOI: 10.1128/IAI.70.3.1367-1371.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection.

Authors:  C Y Chen; R C Ballard; C M Beck-Sague; Y Dangor; F Radebe; S Schmid; J B Weiss; V Tshabalala; G Fehler; Y Htun; S A Morse
Journal:  Sex Transm Dis       Date:  2000-01       Impact factor: 2.830

2.  The immune response to Haemophilus ducreyi resembles a delayed-type hypersensitivity reaction throughout experimental infection of human subjects.

Authors:  K L Palmer; C T Schnizlein-Bick; A Orazi; K John; C Y Chen; A F Hood; S M Spinola
Journal:  J Infect Dis       Date:  1998-12       Impact factor: 5.226

3.  Periplasmic copper-zinc superoxide dismutase protects Haemophilus ducreyi from exogenous superoxide.

Authors:  L R San Mateo; M M Hobbs; T H Kawula
Journal:  Mol Microbiol       Date:  1998-01       Impact factor: 3.501

4.  A novel heme protein, the Cu,Zn-superoxide dismutase from Haemophilus ducreyi.

Authors:  F Pacello; P R Langford; J S Kroll; C Indiani; G Smulevich; A Desideri; G Rotilio; A Battistoni
Journal:  J Biol Chem       Date:  2001-05-21       Impact factor: 5.157

5.  A histidine-rich metal binding domain at the N terminus of Cu,Zn-superoxide dismutases from pathogenic bacteria: a novel strategy for metal chaperoning.

Authors:  A Battistoni; F Pacello; A P Mazzetti; C Capo; J S Kroll; P R Langford; A Sansone; G Donnarumma; P Valenti; G Rotilio
Journal:  J Biol Chem       Date:  2001-05-21       Impact factor: 5.157

6.  Expression of sialylated or paragloboside-like lipooligosaccharides are not required for pustule formation by Haemophilus ducreyi in human volunteers.

Authors:  R S Young; K Fortney; J C Haley; A F Hood; A A Campagnari; J Wang; J A Bozue; R S Munson; S M Spinola
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

7.  Cumulative experience with Haemophilus ducreyi 35000 in the human model of experimental infection.

Authors:  J A Al-Tawfiq; J Harezlak; B P Katz; S M Spinola
Journal:  Sex Transm Dis       Date:  2000-02       Impact factor: 2.830

8.  Localization of Haemophilus ducreyi at the pustular stage of disease in the human model of infection.

Authors:  M E Bauer; S M Spinola
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

9.  Evaluation of an isogenic hemolysin-deficient mutant in the human model of Haemophilus ducreyi infection.

Authors:  K L Palmer; A C Thornton; K R Fortney; A F Hood; R S Munson; S M Spinola
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

10.  Standardization of the experimental model of Haemophilus ducreyi infection in human subjects.

Authors:  J A Al-Tawfiq; A C Thornton; B P Katz; K R Fortney; K D Todd; A F Hood; S M Spinola
Journal:  J Infect Dis       Date:  1998-12       Impact factor: 5.226

View more
  12 in total

Review 1.  Immunopathogenesis of Haemophilus ducreyi infection (chancroid).

Authors:  Stanley M Spinola; Margaret E Bauer; Robert S Munson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

2.  Differences in host susceptibility to disease progression in the human challenge model of Haemophilus ducreyi infection.

Authors:  Stanley M Spinola; Cliffton T H Bong; Andrew L Faber; Kate R Fortney; Stacy L Bennett; Carisa A Townsend; Beth E Zwickl; Steven D Billings; Tricia L Humphreys; Margaret E Bauer; Barry P Katz
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

3.  Effect of superoxide dismutase gene inactivation on virulence of Pseudomonas aeruginosa PAO1 toward the silkworm, Bombyx mori.

Authors:  Kazuhiro Iiyama; Yuuka Chieda; Jae Man Lee; Takahiro Kusakabe; Chisa Yasunaga-Aoki; Susumu Shimizu
Journal:  Appl Environ Microbiol       Date:  2007-01-12       Impact factor: 4.792

4.  Role played by CD4+FOXP3+ regulatory T Cells in suppression of host responses to Haemophilus ducreyi during experimental infection of human volunteers.

Authors:  Wei Li; Klara Tenner-Racz; Paul Racz; Diane M Janowicz; Kate R Fortney; Barry P Katz; Stanley M Spinola
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

5.  A Class I Haemophilus ducreyi Strain Containing a Class II hgbA Allele Is Partially Attenuated in Humans: Implications for HgbA Vaccine Efficacy Trials.

Authors:  Isabelle Leduc; Kate R Fortney; Diane M Janowicz; Beth Zwickl; Sheila Ellinger; Barry P Katz; Huaiying Lin; Qunfeng Dong; Stanley M Spinola
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

6.  Proteomic alterations explain phenotypic changes in Sinorhizobium meliloti lacking the RNA chaperone Hfq.

Authors:  Lise Barra-Bily; Catherine Fontenelle; Gwenael Jan; Maud Flechard; Annie Trautwetter; Shree P Pandey; Graham C Walker; Carlos Blanco
Journal:  J Bacteriol       Date:  2010-01-15       Impact factor: 3.490

7.  Haemophilus ducreyi requires an intact flp gene cluster for virulence in humans.

Authors:  Stanley M Spinola; Kate R Fortney; Barry P Katz; Jo L Latimer; Jason R Mock; Merja Vakevainen; Eric J Hansen
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

8.  A humoral immune response confers protection against Haemophilus ducreyi infection.

Authors:  Leah E Cole; Kristen L Toffer; Robert A Fulcher; Lani R San Mateo; Paul E Orndorff; Thomas H Kawula
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

9.  Experimental infection of human volunteers with Haemophilus ducreyi: fifteen years of clinical data and experience.

Authors:  Diane M Janowicz; Susan Ofner; Barry P Katz; Stanley M Spinola
Journal:  J Infect Dis       Date:  2009-06-01       Impact factor: 5.226

10.  Activation of CpxRA in Haemophilus ducreyi primarily inhibits the expression of its targets, including major virulence determinants.

Authors:  Dharanesh Gangaiah; Xinjun Zhang; Kate R Fortney; Beth Baker; Yunlong Liu; Robert S Munson; Stanley M Spinola
Journal:  J Bacteriol       Date:  2013-05-31       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.